Citigroup’s Jasper Therapeutics JSPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,057
| Closed | -$34.6K | – | 4948 |
|
|
2025
Q1 | $34.6K | Sell |
8,057
-1,003
| -11% | -$4.31K | ﹤0.01% | 4212 |
|
|
2024
Q4 | $194K | Buy |
9,060
+895
| +11% | +$19.1K | ﹤0.01% | 3605 |
|
|
2024
Q3 | $154K | Buy |
8,165
+5,702
| +232% | +$107K | ﹤0.01% | 3771 |
|
|
2024
Q2 | $55.9K | Sell |
2,463
-4,900
| -67% | -$111K | ﹤0.01% | 3784 |
|
|
2024
Q1 | $216K | Buy |
+7,363
| New | +$216K | ﹤0.01% | 3256 |
|
|
2023
Q2 | – | Sell |
-64,810
| Closed | -$117K | – | 4842 |
|
|
2023
Q1 | $117K | Buy |
+64,810
| New | +$117K | ﹤0.01% | 3335 |
|
|
2022
Q3 | – | Sell |
-195
| Closed | – | – | 5199 |
|
|
2022
Q2 | $0 | Buy |
+195
| New | – | ﹤0.01% | 5557 |
|
|
2021
Q3 | – | Sell |
-20,000
| Closed | -$199K | – | 5265 |
|
|
2021
Q2 | $199K | Hold |
20,000
| – | – | ﹤0.01% | 3580 |
|
|
2021
Q1 | $199K | Hold |
20,000
| – | – | ﹤0.01% | 3362 |
|
|
2020
Q4 | $200K | Hold |
20,000
| – | – | ﹤0.01% | 3231 |
|
|
2020
Q3 | $198K | Buy |
+20,000
| New | +$198K | ﹤0.01% | 2786 |
|